Alan Glassberg, Director at BIOGEN IDEC INC. (BIIB), sold 10,000 shares at $61.79 ($617K) on 2008-04-29, disclosed to the SEC on 2008-05-01.
Scheduled sale ($617k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.28 | 300 | $18K | 3.0% |
| 2 | $61.32 | 200 | $12K | 2.0% |
| 3 | $61.35 | 100 | $6K | 1.0% |
| 4 | $61.39 | 300 | $18K | 3.0% |
| 5 | $61.40 | 200 | $12K | 2.0% |
| 6 | $61.45 | 200 |
| $12K |
| 2.0% |
| 7 | $61.47 | 200 | $12K | 2.0% |
| 8 | $61.48 | 100 | $6K | 1.0% |
| 9 | $61.49 | 300 | $18K | 3.0% |
| 10 | $61.50 | 600 | $37K | 6.0% |
| 11 | $61.51 | 400 | $25K | 4.0% |
| 12 | $61.57 | 800 | $49K | 8.0% |
| 13 | $61.64 | 100 | $6K | 1.0% |
| 14 | $61.66 | 700 | $43K | 7.0% |
| 15 | $61.67 | 600 | $37K | 6.0% |
| 16 | $61.68 | 200 | $12K | 2.0% |
| 17 | $61.69 | 200 | $12K | 2.0% |
| 18 | $61.70 | 300 | $19K | 3.0% |
| 19 | $61.73 | 1,400 | $86K | 14.0% |
| 20 | $61.74 | 400 | $25K | 4.0% |
| 21 | $61.76 | 300 | $19K | 3.0% |
| 22 | $61.77 | 400 | $25K | 4.0% |
| 23 | $61.78 | 200 | $12K | 2.0% |
| 24 | $61.79 | 500 | $31K | 5.0% |
| 25 | $61.83 | 200 | $12K | 2.0% |
| 26 | $61.87 | 300 | $19K | 3.0% |
| 27 | $62.00 | 300 | $19K | 3.0% |
| 28 | $62.24 | 200 | $12K | 2.0% |
| Total | $61.65 avg | 10,000 | $617K | 100% |
| Filing → |
| BIIB | SELL | 2006-11-08 | $108K | — | Filing → |
| BIIB | SELL | 2006-10-03 | $586K | — | Filing → |